Health
Researchers in Japan compare two seroprevalence antibody tests for SARS-CoV-2 – News-Medical.Net
Researchers have shown that using reliable antibody tests in conjunction is an effective way to estimate seroprevalence in low prevalence settings.
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first emerged in Wuhan, China, in December 2019. It has since spread to 192 countries and territories, infecting over 100 million individuals and claiming over 2.2 million lives. To date, Japan has reported 391,945 cases and 5,833 deaths.
A team of researchers in Japan have developed commercially available antibody tests to estimate the seroprevalence of SARS-CoV-2 infection…
-
Noosa News21 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
General23 hours agoEV buses join Perth’s wider suburban network, ‘milestone’ for diesel phase-out
-
Noosa News20 hours agoMissing man, Maroochydore – Queensland Police News
-
General17 hours agoJordan Thompson retires from Wimbledon round-of-16 match with American Taylor Fritz